Wednesday, 27 April 2016

Prosthetic Heart Valves Market Forecast 2007- 2021 United States

Summary

GlobalData’s new report, "United States Prosthetic Heart Valves Market Outlook to 2021", provides key market data on the United States Prosthetic Heart Valves market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size.
The objective is to provide information that represents the most up-to-date data of the industry possible.The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.


Scope
- Market size for Prosthetic Heart Valves market segments - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves. 
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. 
- 2014 company shares and distribution shares data for Prosthetic Heart Valves market. 
- Global corporate-level profiles of key companies operating within the United States Prosthetic Heart Valves market. 
- Key players covered include Edwards Lifesciences Corporation, Medtronic plc, St. Jude Medical, Inc. and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future. 
- Develop market-entry and market expansion strategies. 
- Design competition strategies by identifying who-stands-where in the market. 
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. 
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


 Table of Contents
1 Table of Contents 2
    1.1 List of Tables 5
    1.2 List of Figures 6
2 Introduction 7
    2.1 What Is This Report About? 7
    2.2 Prosthetic Heart Valves Market Segmentation 7
    2.3 Definitions of Markets Covered in the Report 8
3 Prosthetic Heart Valves Market, United States 9
    3.1 Prosthetic Heart Valves Market, United States, Revenue ($m), 2007-2014 9
    3.2 Prosthetic Heart Valves Market, United States, Revenue ($m), 2014-2021 11
      3.2.1 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2007-2014 13
      3.2.2 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2007-2014 15
      3.2.3 Transcatheter Heart Valves Market, United States, Revenue ($m), by Segment, 2007-2014 17
      3.2.4 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2014-2021 18
      3.2.5 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2014-2021 20
      3.2.6 Transcatheter Heart Valves Market, United States, Revenue ($m), by Segment, 2014-2021 22
    3.3 Prosthetic Heart Valves Market, United States, Volume (Units), 2007-2014 24
    3.4 Prosthetic Heart Valves Market, United States, Volume (Units), 2014-2021 26
      3.4.1 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2007-2014 28
      3.4.2 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2007-2014 30
      3.4.3 Transcatheter Heart Valves Market, United States, Volume (Units), by Segment, 2007-2014 32
      3.4.4 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2014-2021 33
      3.4.5 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2014-2021 35
      3.4.6 Transcatheter Heart Valves Market, United States, Volume (Units), by Segment, 2014-2021 37
    3.5 Prosthetic Heart Valves Market, United States, Average Price ($), 2007-2021 39
    3.6 Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 2013-2014 41
    3.7 Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2014 42 


4 Overview of Key Companies in United States, Prosthetic Heart Valves Market 43
    4.1 Edwards Lifesciences Corporation 43
      4.1.1 Company Overview 43
    4.2 Medtronic plc 43
      4.2.1 Company Overview 43
    4.3 St. Jude Medical, Inc. 43
      4.3.1 Company Overview 43
    4.4 Sorin S.p.A. (Inactive) 44
      4.4.1 Company Overview 44
5 Prosthetic Heart Valves Market Pipeline Products 45
6 Financial Deals Landscape 46
    6.1 Acquisition 46
      6.1.1 CryoLife to Acquire On-X Life Technologies for USD130 Million 46
      6.1.2 Abbott Labs Denies Talks to Acquire St. Jude Medical for USD25 Billion 48
      6.1.3 Medtronic Acquires Twelve for up to USD458 Million 49
      6.1.4 Abbott Labs Acquires Remaining Stake in Tendyne for USD250 Million 50
      6.1.5 Medtronic Acquires Aptus Endosystems for USD110 Million 51
    6.2 Venture Financing 52
      6.2.1 Twelve Raises USD35.2 Million in Venture Financing 52
      6.2.2 InterValve Secures USD3 Million from Oxford Finance 53 

Check Discount on this report @ 

7 Recent Developments 54
    7.1 Corporate Communications 54
      7.1.1 Sep 14, 2015: Incoming St. Jude Medical President and CEO Mike Rousseau Announces Executive Leadership Team 54
      7.1.2 Sep 09, 2015: St. Jude Medical Announces Leadership Transition Plan 54
      7.1.3 Aug 05, 2015: St. Jude Medical Appoints David Dvorak to Its Board of Directors 56
      7.1.4 Jul 30, 2015: Edwards Announces Board Change 56
      7.1.5 Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative 


Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)



No comments:

Post a Comment